Literature DB >> 16714280

The potential role of ribosomal frameshifting in generating aberrant proteins implicated in neurodegenerative diseases.

Norma M Wills1, John F Atkins.   

Abstract

Aberrant forms of proteins ubiquitin B and beta-amyloid precusor protein, UBB+1 and APP+1, are implicated in human neurodegenerative diseases. They have their carboxyl-terminal regions derived from an alternative reading frame. Transcription slippage has been invoked to explain the production of these proteins from abnormal mRNA. However, ribosomal frameshifting on wild-type mRNA may account for the great majority of the aberrant protein. Ribosomal frameshifting may also be involved in the progression of triplet expansion diseases such as Huntington's and spinocerebellar ataxias. In a particular spinocerebellar ataxia, SCA3, Toulouse and colleagues recently discovered -1 frameshifting in a transcript containing an expanded CAG-repeat. Antibiotics that affect mammalian ribosomes may have complex effects on frameshifting and disease progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714280      PMCID: PMC1484430          DOI: 10.1261/rna.84406

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  40 in total

Review 1.  P-site tRNA is a crucial initiator of ribosomal frameshifting.

Authors:  Pavel V Baranov; Raymond F Gesteland; John F Atkins
Journal:  RNA       Date:  2004-02       Impact factor: 4.942

2.  Factors that influence selection of coding resumption sites in translational bypassing: minimal conventional peptidyl-tRNA:mRNA pairing can suffice.

Authors:  Alan J Herr; Norma M Wills; Chad C Nelson; Raymond F Gesteland; John F Atkins
Journal:  J Biol Chem       Date:  2004-01-05       Impact factor: 5.157

3.  Molecular architecture of CAG repeats in human disease related transcripts.

Authors:  Gracjan Michlewski; Wlodzimierz J Krzyzosiak
Journal:  J Mol Biol       Date:  2004-07-16       Impact factor: 5.469

Review 4.  Ribosomal frameshifting from -2 to +50 nucleotides.

Authors:  R B Weiss; D M Dunn; J F Atkins; R F Gesteland
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1990

5.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

6.  Normal tRNAs promote ribosomal frameshifting.

Authors:  J F Atkins; R F Gesteland; B R Reid; C W Anderson
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

7.  Slippery runs, shifty stops, backward steps, and forward hops: -2, -1, +1, +2, +5, and +6 ribosomal frameshifting.

Authors:  R B Weiss; D M Dunn; J F Atkins; R F Gesteland
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1987

8.  Low activity of -galactosidase in frameshift mutants of Escherichia coli.

Authors:  J F Atkins; D Elseviers; L Gorini
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

9.  Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo.

Authors:  N T Parkin; M Chamorro; H E Varmus
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation.

Authors:  Gregor Schaffar; Peter Breuer; Raina Boteva; Christian Behrends; Nikolay Tzvetkov; Nadine Strippel; Hideki Sakahira; Katja Siegers; Manajit Hayer-Hartl; F Ulrich Hartl
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

View more
  11 in total

Review 1.  Augmented genetic decoding: global, local and temporal alterations of decoding processes and codon meaning.

Authors:  Pavel V Baranov; John F Atkins; Martina M Yordanova
Journal:  Nat Rev Genet       Date:  2015-08-11       Impact factor: 53.242

Review 2.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

Review 3.  A gripping tale of ribosomal frameshifting: extragenic suppressors of frameshift mutations spotlight P-site realignment.

Authors:  John F Atkins; Glenn R Björk
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

Review 4.  Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use.

Authors:  John F Atkins; Gary Loughran; Pramod R Bhatt; Andrew E Firth; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

Review 5.  Roles of trinucleotide-repeat RNA in neurological disease and degeneration.

Authors:  Ling-Bo Li; Nancy M Bonini
Journal:  Trends Neurosci       Date:  2010-04-14       Impact factor: 13.837

Review 6.  Molecular mechanisms underlying nucleotide repeat expansion disorders.

Authors:  Indranil Malik; Chase P Kelley; Eric T Wang; Peter K Todd
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-17       Impact factor: 113.915

Review 7.  Frameshift variations in the RHD coding sequence: Molecular mechanisms permitting protein expression.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2020-10-09       Impact factor: 3.337

8.  Direct detection of alternative open reading frames translation products in human significantly expands the proteome.

Authors:  Benoît Vanderperre; Jean-François Lucier; Cyntia Bissonnette; Julie Motard; Guillaume Tremblay; Solène Vanderperre; Maxence Wisztorski; Michel Salzet; François-Michel Boisvert; Xavier Roucou
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 9.  RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders.

Authors:  Marzena Wojciechowska; Marta Olejniczak; Paulina Galka-Marciniak; Magdalena Jazurek; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2014-09-12       Impact factor: 16.971

10.  Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.

Authors:  Michel J Grothe; Jorge Sepulcre; Gabriel Gonzalez-Escamilla; Irina Jelistratova; Michael Schöll; Oskar Hansson; Stefan J Teipel
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.